title: Cannabinoids as therapeutic agents for ablating neuroinflammatory disease.
abstract: Cannabinoids have been reported to alter the activities of immune cells in vitro and in vivo. These compounds may serve as ideal agents for adjunct treatment of pathological processes that have a neuroinflammatory component. As highly lipophilic molecules, they readily access the brain. Furthermore, they have relatively low toxicity and can be engineered to selectively target cannabinoid receptors. To date, two cannabinoid receptors have been identified, characterized and designated CB(1) and CB(2). CB(1) appears to be constitutively expressed within the CNS while CB(2) apparently is induced during inflammation. The inducible nature of expression of CB(2) extends to microglia, the resident macrophages of the brain that play a critical role during early stages of inflammation in that compartment. Thus, the cannabinoid-cannabinoid receptor system may prove therapeutically manageable in ablating neuropathogenic disorders such as Alzheimer's disease, multiple sclerosis, amyotrophic lateral sclerosis, HIV encephalitis, closed head injury, and granulomatous amebic encephalitis.
authors.affiliation: Department of Microbiology and Immunology, Virginia Commonwealth University, School of Medicine, 1101 E. Marshall Street, Richmond, Virginia 23298-0678 USA. gacabral@vcu.edu
authors.forename: G A
authors.initials: GA
authors.lastname: Cabral
authors.forename: L
authors.initials: L
authors.lastname: Griffin-Thomas
mesh_terms: D000818:Animals; D063385:Cannabinoid Receptor Modulators / Q000378:metabolism / Q000502:physiology; D002186:Cannabinoids / Q000378:metabolism / Q000627:therapeutic use*; D006801:Humans; D007109:Immunity / Q000187:drug effects; D007249:Inflammation / Q000188:drug therapy*; D009422:Nervous System Diseases / Q000188:drug therapy*; D043882:Receptors, Cannabinoid / Q000187:drug effects; D015398:Signal Transduction / Q000187:drug effects
chemical_list: D063385:Cannabinoid Receptor Modulators; D002186:Cannabinoids; D043882:Receptors, Cannabinoid
references.citation: Science. 1992 Mar 6;255(5049):1246-9
references.pmid: 1546323
references.citation: Neurosci Lett. 2007 Jan 29;412(2):114-7
references.pmid: 17123706
references.citation: Clin Microbiol Rev. 2003 Apr;16(2):273-307
references.pmid: 12692099
references.citation: J Neurosci. 2003 Mar 15;23(6):2371-82
references.pmid: 12657697
references.citation: Pediatr Res. 2006 Aug;60(2):169-73
references.pmid: 16864698
references.citation: Nat Med. 2007 Apr;13(4):492-7
references.pmid: 17401376
references.citation: Glia. 2000 Jan 1;29(1):58-69
references.pmid: 10594923
references.citation: Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8658-62
references.pmid: 8378344
references.citation: Toxicol Appl Pharmacol. 2005 Jun 1;205(2):107-15
references.pmid: 15893538
references.citation: J Neurosci. 2007 Feb 28;27(9):2396-402
references.pmid: 17329437
references.citation: Immunopharmacology. 1998 Nov;40(3):179-85
references.pmid: 9858061
references.citation: J Immunol. 1998 May 15;160(10):4671-80
references.pmid: 9590212
references.citation: J Neurosci. 1986 Aug;6(8):2163-78
references.pmid: 3018187
references.citation: J Med Primatol. 1992 Feb-May;21(2-3):59-63
references.pmid: 1359149
references.citation: Biochem Pharmacol. 2006 Sep 28;72(7):869-80
references.pmid: 16914119
references.citation: Clin Diagn Lab Immunol. 2002 May;9(3):515-24
references.pmid: 11986254
references.citation: Br J Pharmacol. 2003 Dec;140(8):1351-62
references.pmid: 14645143
references.citation: Lab Invest. 1991 Feb;64(2):135-56
references.pmid: 1997729
references.citation: FEBS Lett. 1995 Nov 13;375(1-2):143-7
references.pmid: 7498464
references.citation: J Neuroimmunol. 2004 Feb;147(1-2):127-30
references.pmid: 14741443
references.citation: Eur J Neurosci. 2004 Nov;20(9):2267-75
references.pmid: 15525268
references.citation: BMC Neurol. 2006 Mar 02;6:12
references.pmid: 16512913
references.citation: J Am Chem Soc. 1971 Jan 13;93(1):217-24
references.pmid: 5538858
references.citation: J Cell Biol. 2003 Nov 10;163(3):463-8
references.pmid: 14610053
references.citation: Neurobiol Dis. 2005 Nov;20(2):207-17
references.pmid: 16242629
references.citation: Am J Pathol. 1991 Sep;139(3):609-21
references.pmid: 1716047
references.citation: Biochem J. 1991 Oct 1;279 ( Pt 1):129-34
references.pmid: 1718258
references.citation: Trends Cell Biol. 1998 Nov;8(11):425-7
references.pmid: 9854307
references.citation: Br J Pharmacol. 2003 Jun;139(4):775-86
references.pmid: 12813001
references.citation: FASEB J. 2006 May;20(7):1003-5
references.pmid: 16571781
references.citation: Trends Neurosci. 1996 Aug;19(8):312-8
references.pmid: 8843599
references.citation: Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14136-41
references.pmid: 10570211
references.citation: Proc Natl Acad Sci U S A. 1990 Mar;87(5):1932-6
references.pmid: 2308954
references.citation: Neurobiol Dis. 2006 May;22(2):257-64
references.pmid: 16364651
references.citation: Nature. 1996 Nov 7;384(6604):83-7
references.pmid: 8900284
references.citation: Life Sci. 2006 Jan 2;78(6):549-63
references.pmid: 16109430
references.citation: Mol Pharmacol. 1988 Nov;34(5):605-13
references.pmid: 2848184
references.citation: Adv Exp Med Biol. 2001;493:207-14
references.pmid: 11727767
references.citation: Brain Res Brain Res Rev. 1995 Mar;20(3):269-87
references.pmid: 7550361
references.citation: J Toxicol Environ Health. 1991 Apr;32(4):465-77
references.pmid: 1850002
references.citation: Eur J Pharmacol. 2000 May 19;396(2-3):141-9
references.pmid: 10822068
references.citation: Brain Pathol. 2001 Jan;11(1):1-11
references.pmid: 11145195
references.citation: Trends Pharmacol Sci. 2007 Jan;28(1):39-45
references.pmid: 17141334
references.citation: J Neurochem. 2007 Apr;101(1):87-98
references.pmid: 17241118
references.citation: Nature. 1994 Jan 13;367(6459):188-93
references.pmid: 8114918
references.citation: Arzneimittelforschung. 1995 Mar;45(3A):357-60
references.pmid: 7763326
references.citation: No To Shinkei. 1992 Feb;44(2):95-102
references.pmid: 1373637
references.citation: J Neurosci Res. 2002 Mar 15;67(6):829-36
references.pmid: 11891798
references.citation: Trends Neurosci. 1988 Jun;11(6):273-7
references.pmid: 2465626
references.citation: Nature. 1997 Aug 21;388(6644):773-8
references.pmid: 9285589
references.citation: Science. 1985 Oct 4;230(4721):71-3
references.pmid: 2412295
references.citation: Int Rev Cytol. 1997;171:167-224
references.pmid: 9066128
references.citation: FEBS Lett. 1998 Jan 23;422(1):69-73
references.pmid: 9475172
references.citation: Mol Pharmacol. 1995 Aug;48(2):352-61
references.pmid: 7651369
references.citation: J Clin Invest. 2003 Apr;111(8):1231-40
references.pmid: 12697742
references.citation: Mol Pharmacol. 1984 Nov;26(3):532-8
references.pmid: 6092901
references.citation: Mt Sinai J Med. 1993 Sep;60(4):271-8
references.pmid: 8232369
references.citation: Toxicol Appl Pharmacol. 1997 Feb;142(2):278-87
references.pmid: 9070350
references.citation: Proc Soc Exp Biol Med. 1995 Oct;210(1):64-76
references.pmid: 7675800
references.citation: Eur J Biochem. 1995 Aug 15;232(1):54-61
references.pmid: 7556170
references.citation: Glia. 1992;6(1):39-47
references.pmid: 1380949
references.citation: Biochem J. 1995 Dec 1;312 ( Pt 2):637-41
references.pmid: 8526880
references.citation: Int Immunopharmacol. 2002 Jan;2(1):69-82
references.pmid: 11789671
references.citation: Chem Phys Lipids. 2000 Nov;108(1-2):53-70
references.pmid: 11106782
references.citation: J Neuroimmunol. 1997 Feb;72(2):169-77
references.pmid: 9042110
references.citation: DNA Seq. 1995;5(6):385-8
references.pmid: 8777318
references.citation: Neurobiol Aging. 1997 Jul-Aug;18(4 Suppl):S21-6
references.pmid: 9330981
references.citation: FEBS Lett. 1998 Aug 14;433(1-2):139-42
references.pmid: 9738948
references.citation: J Neurosci. 2005 Mar 9;25(10):2530-6
references.pmid: 15758162
references.citation: Nature. 1993 Sep 2;365(6441):61-5
references.pmid: 7689702
references.citation: J Biol Chem. 2004 Feb 13;279(7):5298-305
references.pmid: 14634025
references.citation: J Neuroimmunol. 2006 Dec;181(1-2):82-92
references.pmid: 17045344
references.citation: Mol Pharmacol. 1986 Mar;29(3):307-13
references.pmid: 2869405
references.citation: Neuroscience. 1994 Dec;63(3):637-52
references.pmid: 7898667
references.citation: FEBS Lett. 2005 Nov 21;579(28):6473-8
references.pmid: 16288744
references.citation: Mol Immunol. 2006 Jul;43(14):2169-79
references.pmid: 16503355
references.citation: J Neurosci. 2003 Dec 3;23(35):11136-41
references.pmid: 14657172
references.citation: Handb Exp Pharmacol. 2005;(168):385-423
references.pmid: 16596782
references.citation: J Virol. 1994 Nov;68(11):7099-107
references.pmid: 7933091
references.citation: Biochem Pharmacol. 1995 Jun 29;50(1):83-90
references.pmid: 7605349
references.citation: Nature. 2001 Oct 4;413(6855):527-31
references.pmid: 11586361
references.citation: Neurol Res. 1995 Aug;17(4):275-80
references.pmid: 7477742
references.citation: J Neurochem. 2004 Jun;89(6):1555-7
references.pmid: 15189359
references.citation: Science. 1992 Dec 18;258(5090):1946-9
references.pmid: 1470919
references.citation: Mol Pharmacol. 2001 Jul;60(1):155-63
references.pmid: 11408610
references.citation: Immunol Today. 1998 Aug;19(8):373-81
references.pmid: 9709506
references.citation: Glia. 2005 Jan 15;49(2):211-9
references.pmid: 15390091
references.citation: J Neuroinflammation. 2005 Dec 12;2:29
references.pmid: 16343349
references.citation: Adv Neuroimmunol. 1994;4(3):257-60
references.pmid: 7874392
references.citation: FASEB J. 1991 Jul;5(10):2391-7
references.pmid: 2065887
references.citation: J Neurotrauma. 1993 Summer;10(2):109-19
references.pmid: 8411215
references.citation: Philos Trans R Soc Lond B Biol Sci. 2001 Mar 29;356(1407):381-408
references.pmid: 11316486
references.citation: J Mol Med (Berl). 1997 Mar;75(3):165-73
references.pmid: 9106073
references.citation: Eur J Biochem. 1996 Aug 15;240(1):53-62
references.pmid: 8797835
references.citation: Neuroreport. 1997 May 27;8(8):1929-33
references.pmid: 9223079
references.citation: Res Virol. 1996 Mar-Jun;147(2-3):79-88
references.pmid: 8901425
references.citation: Brain. 2003 Oct;126(Pt 10):2191-202
references.pmid: 12876144
references.citation: Brain Res. 2006 Aug 30;1107(1):199-205
references.pmid: 16822488
references.citation: J Neuroimmunol. 2006 Dec;181(1-2):57-67
references.pmid: 17011047
references.citation: J Pharmacol Sci. 2004 Dec;96(4):362-6
references.pmid: 15599103
references.citation: J Neurosci. 2005 Feb 23;25(8):1904-13
references.pmid: 15728830
references.citation: J Pharmacol Exp Ther. 2000 Mar;292(3):886-94
references.pmid: 10688601
references.citation: Synapse. 2004 Sep 15;53(4):208-13
references.pmid: 15266552
references.citation: Chem Phys Lipids. 2002 Dec 31;121(1-2):57-63
references.pmid: 12505690
references.citation: Biochem Biophys Res Commun. 1996 Jan 5;218(1):113-7
references.pmid: 8573114
references.citation: J Neurochem. 2005 Oct;95(2):437-45
references.pmid: 16086683
references.citation: Glia. 1993 Jan;7(1):9-18
references.pmid: 8423067
references.citation: FASEB J. 2005 Aug;19(10):1338-40
references.pmid: 15941768
references.citation: Mol Cell Neurosci. 2007 Apr;34(4):551-61
references.pmid: 17229577
references.citation: Br J Pharmacol. 2007 Nov;152(5):624-32
references.pmid: 17704819
references.citation: Eur J Pharmacol. 2006 Aug 7;542(1-3):100-5
references.pmid: 16781706
references.citation: Biochim Biophys Acta. 1996 Jun 7;1307(2):132-6
references.pmid: 8679694
references.citation: Crit Care Med. 2002 Mar;30(3):548-54
references.pmid: 11990913
references.citation: J Neurosci. 1997 Feb 15;17(4):1226-42
references.pmid: 9006968
references.citation: Eur J Neurosci. 2006 Mar;23(6):1530-8
references.pmid: 16553616
references.citation: J Leukoc Biol. 2003 Oct;74(4):486-96
references.pmid: 12960289
references.citation: Trends Cell Biol. 1998 Nov;8(11):447-53
references.pmid: 9854312
references.citation: J Pharmacol Exp Ther. 1999 Jun;289(3):1620-5
references.pmid: 10336560
references.citation: Biochem J. 1998 Apr 1;331 ( Pt 1):15-9
references.pmid: 9512456
references.citation: J Pharmacol Exp Ther. 1998 Feb;284(2):644-50
references.pmid: 9454810
references.citation: FASEB J. 2000 Jul;14(10):1432-8
references.pmid: 10877836
references.citation: Biochem Pharmacol. 1996 Sep 13;52(5):743-51
references.pmid: 8765472
references.citation: Neurobiol Aging. 1988 Jul-Aug;9(4):339-49
references.pmid: 3263583
references.citation: Mol Pharmacol. 1985 Apr;27(4):429-36
references.pmid: 2984538
references.citation: J Neuroimmunol. 1998 Feb;82(1):13-21
references.pmid: 9526841
references.citation: J Neurochem. 2000 Dec;75(6):2434-44
references.pmid: 11080195
references.citation: Int J Immunopharmacol. 1992 Nov;14(8):1445-52
references.pmid: 1334476
references.citation: J Neurosci. 2003 Apr 1;23(7):2511-6
references.pmid: 12684434
references.citation: Brain Res. 1995 Jul 10;685(1-2):1-11
references.pmid: 7583233
references.citation: J Pharmacol Exp Ther. 1993 Dec;267(3):1558-65
references.pmid: 8263818
references.citation: Eur J Biochem. 1996 May 1;237(3):704-11
references.pmid: 8647116
references.citation: Biochem Pharmacol. 2006 Dec 15;72(12):1697-706
references.pmid: 17007821
references.citation: Mult Scler. 2004 Apr;10(2):158-64
references.pmid: 15124761
references.citation: Neuroscience. 2007 Feb 23;144(4):1516-22
references.pmid: 17178196
references.citation: Glia. 1988;1(5):301-7
references.pmid: 2976393
references.citation: Annu Rev Microbiol. 1992;46:655-93
references.pmid: 1444270
references.citation: Neuroscience. 2005;134(1):261-8
references.pmid: 15953683
references.citation: Dev Neurosci. 1993;15(6):423-32
references.pmid: 7835248
references.citation: J Neurosci. 2003 Feb 15;23(4):1398-405
references.pmid: 12598628
references.citation: Ann N Y Acad Sci. 1988;540:319-23
references.pmid: 3061340
references.citation: J Neuroimmunol. 2000 Sep 22;109(2):155-63
references.pmid: 10996217
references.citation: J Leukoc Biol. 2005 Dec;78(6):1192-7
references.pmid: 16204639
references.citation: J Leukoc Biol. 1999 Apr;65(4):466-74
references.pmid: 10204575
references.citation: Glia. 2003 Jan 15;41(2):161-8
references.pmid: 12509806
references.citation: J Neuroimmune Pharmacol. 2008 Jun;3(2):117-29
references.pmid: 18247131
references.citation: Neuron. 2006 Jan 5;49(1):67-79
references.pmid: 16387640
references.citation: Eur J Pharmacol. 2003 Aug 8;474(2-3):195-8
references.pmid: 12921861
references.citation: J Neurosci. 2003 Jul 23;23(16):6470-4
references.pmid: 12878687
references.citation: Amyotroph Lateral Scler Other Motor Neuron Disord. 2005 Sep;6(3):182-4
references.pmid: 16183560
references.citation: Nature. 1990 Aug 9;346(6284):561-4
references.pmid: 2165569
references.citation: Br J Pharmacol. 2007 Feb;150(4):519-25
references.pmid: 17220914